Skip to main content

Advertisement

SpringerLink
Log in

Advances in the Diagnosis and Treatment of Barrett’s Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium

  • Review Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Patients with Barrett’s esophagus (BE) are at increased risk of developing esophageal adenocarcinoma (EAC). The incidence of EAC is rising faster than any other cancer.

Discussion

Patients with BE have a 30- to 40-fold increased risk of EAC. In the past 20 years, there have been dramatic advances in our understanding of the incidence and natural history of BE. Endoscopic treatment of BE is evolving. Even early EAC has been treated without esophagectomy and good oncologic results in the modern era.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sharma P, Dent J, Armstrong D Bergman JJ, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GN, Vieth M. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392–9

    Article  PubMed  Google Scholar 

  2. Bremner CG, Lynch VP, Ellis FH. Barrett’s esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970;68:209–16.

    CAS  PubMed  Google Scholar 

  3. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett’s esophagus. N Engl J Med 1976; 295:476–80

    Article  CAS  PubMed  Google Scholar 

  4. Kapoor H, Agrawal DK, Mittal SK. Barrett’s Esophagus: recent insights in to pathogenesis and cellular ontogeny. Translational Research 2015; 166(1): 28–40

    Article  CAS  PubMed  Google Scholar 

  5. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011;140(3):1084

    Article  Google Scholar 

  6. Shaheen NJ, Falk GW, Iyer PG, Gerson LB, American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol 2016;111(1):30

    Article  CAS  PubMed  Google Scholar 

  7. Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS. Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas. Gastroenterology 2013; 145(2):312–9

    Article  PubMed  PubMed Central  Google Scholar 

  8. Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, Woods K, Almario JA, Schell U, Goldblum J, Maitra A, Montgomery E, Kiesslich R; Confocal Endomicroscopy for Barrett’s Esophagus or Confocal Endomicroscopy for Barrett’s Esophagus (CEBE) Trial Group. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial. Gastrointest Endosc 2014;79(2):211–21

    Article  PubMed  Google Scholar 

  9. Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ. Radiofrequency ablation vs. endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 2014;311(12):1209–17

    Article  CAS  PubMed  Google Scholar 

  10. Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett’s Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11(10):1245–55.

    Article  PubMed  Google Scholar 

  11. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008;57(9):1200–6.

    Article  CAS  PubMed  Google Scholar 

  12. van Vilsteren FG, Pouw RE, Seewald S, Alvarez Herrero L, Sondermeijer CM, Visser M, Ten Kate FJ, Yu Kim Teng KC, Soehendra N, Rösch T, Weusten BL, Bergman JJ. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011;60 (6):765–73.

    Article  PubMed  Google Scholar 

  13. Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 2015;64(8):1192–9

    Article  CAS  PubMed  Google Scholar 

  14. Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, Wang KK, Fleischer DE, Sharma VK, Eisen GM, Fennerty MB, Hunter JG, Bronner MP, Goldblum JR, Bennett AE, Mashimo H, Rothstein RI, Gordon SR, Edmundowicz SA, Madanick RD, Peery AF, Muthusamy VR, Chang KJ, Kimmey MB, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Dumot JA, Falk GW, Galanko JA, Jobe BA, Hawes RH, Hoffman BJ, Sharma P, Chak A, Lightdale CJ. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 2011;141(2):460–8.

  15. Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium. Gastroenterology 2013; 145(1):79–86

    Article  PubMed  PubMed Central  Google Scholar 

  16. Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BL, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, ten Kate FJ, Ell C, Neuhaus H, Bergman JJ. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut 2016;65(4):555–62

    Article  CAS  PubMed  Google Scholar 

  17. Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS, Dellon ES, Lyday WD, Ertan A, Chmielewski GW, Shaheen NJ. Durability and predictors of successful radiofrequency ablation for Barrett’s esophagus. Clin Gastroenterol Hepatol 2014;12(11):1840–7

    Article  PubMed  PubMed Central  Google Scholar 

  18. Krishnamoorthi R, Singh S, Ragunathan K, A Katzka D, K Wang K, G Iyer P. Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy: a systematic review and meta-analysis. Gastrointest Endosc 2016;83(6):1090–1106

    Article  PubMed  PubMed Central  Google Scholar 

  19. Krishnan K, Pandolfino JE, Kahrilas PJ, Keefer L, Boris L, Komanduri S. Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 2012;143(3):576–81.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Parrilla P, Martinez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 2003;237:291–8.

    PubMed  PubMed Central  Google Scholar 

  21. Attwood SE, Lundell L, Hatlebakk JG, Eklund S, Junghard O, Galmiche JP, Ell C, Fiocca R, Lind T. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg 2008;12:1646–54

    Article  CAS  PubMed  Google Scholar 

  22. Ferraris R, Fracchia M, Foti M, Sidoli L, Taraglio S, Vigano’ L, Giaccone C, Rebecchi F, Meineri G, Senore C, Pera A; Gruppo Operativo Studio Precancerosi Esofagee. Barrett’s oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment Pharmacol Ther 2007;25:835–40.

    Article  CAS  PubMed  Google Scholar 

  23. Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF. Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry. J Gastrointest Surg 2013;17:21–8

    Article  PubMed  Google Scholar 

  24. Skrobic O, Simic A, Radovanovic N, Ivanović N, Micev M, Peško P. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett’s esophagus. Surg Endosc 2016;30(9):3802–7

    Article  PubMed  Google Scholar 

  25. Chang EY, Morris CD, Seltman AK, O’Rourke RW, Chan BK, Hunter JG, Jobe BA. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg 2007;246:11–21.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Knight BC, Devitt PG, Watson DI, Smith LT, Jamieson GG, Thompson SK. Long-term Efficacy of Laparoscopic Antireflux Surgery on Regression of Barrett’s Esophagus Using BRAVO Wireless pH Monitoring: A Prospective Clinical Cohort Study. Ann Surg 2016 Oct 4. [Epub ahead of print]

  27. Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014;146(3):652–660

    Article  PubMed  Google Scholar 

  28. Schmidt HM, Mohiuddin K, Bodnar AM, El Lakis M, Kaplan S, Irani S, Gan I, Ross A, Low DE. Multidisciplinary treatment of T1a adenocarcinoma in Barrett’s esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients. Surg Endosc 2016; 30:3391–401.

    Article  PubMed  Google Scholar 

  29. Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc 2014; 79:224–232.

    Article  PubMed  Google Scholar 

  30. Huntington JT, Walker JP, Meara MP, Hazey JW, Melvin WS, Perry KA. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc 2015; 29:2121–2125.

    Article  PubMed  Google Scholar 

  31. Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG. Long-term outcomes of patients with Barrett’s esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointest Endosc 2013;77(2):190–9

    Article  PubMed  Google Scholar 

  32. Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 2017;21(1):62–67

    Article  PubMed  Google Scholar 

  33. Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A, Gossner L, Stolte M, Vieth M, Ell C. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013; 11:630–5.

    Article  PubMed  Google Scholar 

  34. Luna RA, Gilbert E, Hunter JG. High-grade dysplasia and intramucosal adenocarcinoma in Barrett’s esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol. 2012 Jul;28(4):362–9

  35. Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG. Long-term outcomes of patients with Barrett’s esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication. Gastrointest Endosc. 2013 Feb;77(2):190–9

Download references

Authors contributions

All listed co-authors and authors meet ICMJE criteria for authorship. Each listed author contributed to the design of this work, created a draft for a substantial part of the manuscript, approved the submitted version, and is accountable for all aspects of this work.

Author information

Authors and Affiliations

  1. Division of General Surgery, Department of Surgery, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI, 53226, USA

    Jon C. Gould

  2. University of Washington, Seattle, WA, USA

    Mark R. Wendling & Brant K. Oeschlager

  3. Creighton University, Omaha, NE, USA

    Sumeet K. Mittal

  4. Northwestern University, Chicago, IL, USA

    Srinadh Komanduri

  5. Ohio State University, Columbus, OH, USA

    Kyle A. Perry

  6. University of Toronto, Toronto, ON, Canada

    Sean Cleary

  7. University of Louisville, Louisville, KY, USA

    Susan Galandiuk

  8. University of Texas Southwestern, Dallas, TX, USA

    Daniel J. Scott

  9. Harvard Medical School, Boston, MA, USA

    P. Marco Fisichella

  10. University of North Carolina, Chapel Hill, NC, USA

    Nicholas J. Shaheen

  11. Oregon Health Sciences University, Portland, OR, USA

    Kelly R. Haisley & John G. Hunter

Authors
  1. Jon C. Gould
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark R. Wendling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brant K. Oeschlager
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sumeet K. Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Srinadh Komanduri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyle A. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sean Cleary
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susan Galandiuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Daniel J. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P. Marco Fisichella
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nicholas J. Shaheen
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kelly R. Haisley
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. John G. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jon C. Gould.

Additional information

Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium, Digestive Disease Week, San Diego, May 24, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gould, J.C., Wendling, M.R., Oeschlager, B.K. et al. Advances in the Diagnosis and Treatment of Barrett’s Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg 21, 1342–1349 (2017). https://doi.org/10.1007/s11605-017-3390-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-017-3390-5

Keywords

Search

Navigation